Skip to main content

Table 3 Risk of pulmonary embolism associated with antipsychotic use: subgroup analysis for age and gender

From: Antipsychotic drug exposure and risk of pulmonary embolism: a population-based, nested case–control study

  Adjusted* odds ratios (95% confidence interval) for current use vs past use for each subgroup  
  age < 65 age ≥ 65 Total
Women 0.77 (0.08 - 7.17) 4.96 (1.55 - 15.9) 3.94 (1.43 - 10.88)
Men 0.5 (0.13 - 1.93) 1.7 (0.39 - 7.31) 1.03 (0.4 - 2.68)
Total 0.6 (0.19 - 1.89) 3.65 (1.48 - 9.04) 2.31 (1.16 - 4.59)
  1. *adjusted for psychiatric hospitalization, coronary heart disease, heart failure, stroke, chronic liver disease, Parkinson’s disease, chronic renal disease, utilization of lithium, statins, NSAID, antiplatlet treatment, antidiabetic and antihypertensive agents.